181 related articles for article (PubMed ID: 35428957)
21. EGFR-TKIs versus taxanes agents in therapy for nonsmall-cell lung cancer patients: A PRISMA-compliant systematic review with meta-analysis and meta-regression.
An N; Zhang Y; Niu H; Li Z; Cai J; Zhao Q; Li Q
Medicine (Baltimore); 2016 Dec; 95(50):e5601. PubMed ID: 27977598
[TBL] [Abstract][Full Text] [Related]
22. Retrospective analyses of cisplatin-based doublet combination chemotherapy in patients with advanced gastric cancer.
Lim DH; Park SH; Park KW; Kang JH; Oh SY; Hwang IG; Kwon JM; Lee SC; Lee HY; Kim HS; Lim HY; Kang WK
BMC Cancer; 2010 Oct; 10():583. PubMed ID: 20977739
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of docetaxel or epirubicin, combined with cisplatin and fluorouracil (DCF and ECF), regimens as first line chemotherapy for advanced gastric cancer: a retrospective analysis from Turkey.
Teker F; Yilmaz B; Kemal Y; Kut E; Yucel I
Asian Pac J Cancer Prev; 2014; 15(16):6727-32. PubMed ID: 25169516
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of nanoparticle-albumin-bound paclitaxel compared with conventional taxanes in women with breast cancer: a systematic review and meta-analysis.
Lei L; Chen R; Fan L; Zheng W; Wang X
Ann Palliat Med; 2022 Jul; 11(7):2382-2394. PubMed ID: 35927773
[TBL] [Abstract][Full Text] [Related]
25. Comparative Effectiveness of Taxane-Containing Regimens for Treatment of HER2-Negative Metastatic Breast Cancer: A Network Meta-analysis.
Dong L; Zhu LN; Xie BJ; Li JB; Ding T; Jiang YF; Zhu ZN
Pharmacotherapy; 2019 Dec; 39(12):1126-1136. PubMed ID: 31692005
[TBL] [Abstract][Full Text] [Related]
26. Second-line chemotherapy using taxane in patients with advanced gastric cancer who presented with severe peritoneal metastasis: a multicenter retrospective study.
Arai H; Kawahira M; Yasui H; Masuishi T; Muro K; Nakajima TE
Int J Clin Oncol; 2021 Feb; 26(2):355-363. PubMed ID: 33063177
[TBL] [Abstract][Full Text] [Related]
27. Single-agent Taxane Versus Taxane-containing Combination Chemotherapy as Salvage Therapy for Advanced Urothelial Carcinoma.
Sonpavde G; Pond GR; Choueiri TK; Mullane S; Niegisch G; Albers P; Necchi A; Di Lorenzo G; Buonerba C; Rozzi A; Matsumoto K; Lee JL; Kitamura H; Kume H; Bellmunt J
Eur Urol; 2016 Apr; 69(4):634-641. PubMed ID: 26264159
[TBL] [Abstract][Full Text] [Related]
28. Docetaxel, cisplatin and fluorouracil (DCF) regimen compared with non-taxane-containing palliative chemotherapy for gastric carcinoma: a systematic review and meta-analysis.
Chen XL; Chen XZ; Yang C; Liao YB; Li H; Wang L; Yang K; Li K; Hu JK; Zhang B; Chen ZX; Chen JP; Zhou ZG
PLoS One; 2013; 8(4):e60320. PubMed ID: 23593191
[TBL] [Abstract][Full Text] [Related]
29. A phase II study of irinotecan and docetaxel combination chemotherapy for patients with previously treated metastatic or recurrent advanced gastric cancer.
Sym SJ; Chang HM; Kang HJ; Lee SS; Ryu MH; Lee JL; Kim TW; Yook JH; Oh ST; Kim BS; Kang YK
Cancer Chemother Pharmacol; 2008 Dec; 63(1):1-8. PubMed ID: 18288477
[TBL] [Abstract][Full Text] [Related]
30. Meta-analysis of phase III trials of docetaxel alone or in combination with chemotherapy in metastatic breast cancer.
Belfiglio M; Fanizza C; Tinari N; Ficorella C; Iacobelli S; Natoli C;
J Cancer Res Clin Oncol; 2012 Feb; 138(2):221-9. PubMed ID: 22095437
[TBL] [Abstract][Full Text] [Related]
31. Improved efficacy of taxanes and ramucirumab combination chemotherapy after exposure to anti-PD-1 therapy in advanced gastric cancer.
Sasaki A; Kawazoe A; Eto T; Okunaka M; Mishima S; Sawada K; Nakamura Y; Kotani D; Kuboki Y; Taniguchi H; Kojima T; Doi T; Yoshino T; Akimoto T; Shitara K
ESMO Open; 2020 Jul; 4(Suppl 2):. PubMed ID: 32719002
[TBL] [Abstract][Full Text] [Related]
32. Taxanes alone or in combination with anthracyclines as first-line therapy of patients with metastatic breast cancer.
Piccart-Gebhart MJ; Burzykowski T; Buyse M; Sledge G; Carmichael J; Lück HJ; Mackey JR; Nabholtz JM; Paridaens R; Biganzoli L; Jassem J; Bontenbal M; Bonneterre J; Chan S; Basaran GA; Therasse P
J Clin Oncol; 2008 Apr; 26(12):1980-6. PubMed ID: 18421049
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of angiogenesis inhibitors in advanced gastric cancer: a systematic review and meta-analysis.
Yu J; Zhang Y; Leung LH; Liu L; Yang F; Yao X
J Hematol Oncol; 2016 Oct; 9(1):111. PubMed ID: 27756337
[TBL] [Abstract][Full Text] [Related]
34. Salvage chemotherapy with the combination of oxaliplatin, leucovorin, and 5-fluorouracil in advanced gastric cancer refractory or intolerant to fluoropyrimidines, platinum, taxanes, and irinotecan.
Kondoh C; Kadowaki S; Komori A; Narita Y; Taniguchi H; Ura T; Ando M; Muro K
Gastric Cancer; 2018 Nov; 21(6):1050-1057. PubMed ID: 29658055
[TBL] [Abstract][Full Text] [Related]
35. Taxanes in the Treatment of Advanced Gastric Cancer.
Kang BW; Kwon OK; Chung HY; Yu W; Kim JG
Molecules; 2016 May; 21(5):. PubMed ID: 27196887
[TBL] [Abstract][Full Text] [Related]
36. [Efficacy of cetuximab combined with chemotherapy for patients with advanced colorectal cancer and unclear K-ras status].
Guo GF; Xia LP; Qiu HJ; Xu RH; Zhang B; Jiang WQ; Zhou FF; Wang F
Zhonghua Zhong Liu Za Zhi; 2010 Oct; 32(10):777-81. PubMed ID: 21163071
[TBL] [Abstract][Full Text] [Related]
37. Docetaxel/cisplatin followed by FOLFIRI versus the reverse sequence in metastatic gastric cancer.
Kim JA; Lee J; Han B; Park SH; Park JO; Park YS; Lim HY; Kang WK
Cancer Chemother Pharmacol; 2011 Jul; 68(1):177-84. PubMed ID: 20878159
[TBL] [Abstract][Full Text] [Related]
38. Chemotherapy for advanced gastric cancer.
Wagner AD; Unverzagt S; Grothe W; Kleber G; Grothey A; Haerting J; Fleig WE
Cochrane Database Syst Rev; 2010 Mar; (3):CD004064. PubMed ID: 20238327
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of combining targeted therapy with pemetrexed or docetaxel as second-line treatment in patients with advanced non-small-cell lung cancer: a meta-analysis of 14 randomized controlled trials.
Li X; Wang H; Lin W; Xu Q
Curr Med Res Opin; 2014 Nov; 30(11):2295-304. PubMed ID: 24701984
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and Safety of Low-Dose Apatinib Combined with Chemotherapy as Second-Line Treatment for Advanced Gastric Cancer: A Meta-Analysis.
Wang L; Li J; Chen H
Chemotherapy; 2024; 69(1):11-22. PubMed ID: 37339610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
